| [1] 杨跃梅,沈倍奋.靶向抗肿瘤抗体一药物偶联物研究进展. 国际药学研究杂志, 2014,41(1):15-50. Yang Y M,Shen B F. Development of antibody-drug conjugates as targeted cancer therapeutics. Journal of International Pharmaceutical Research. 2014,41(1):15-50.
[2] Li Z, Fan D, Xiong D.Mesenchymal stem cells as delivery vectors for anti-tumor therapy. Stem Cell Investig.[2017-02-14]. http://sci.amegroups.com/article/view/5978/6693.
[3] Ding D C, Chang Y H, Shyu W C,et al. Human umbilical cord mesenchymal stem cells:a new era for stem cell therapy. Cell Transplant, 2015,24(3):339-347.
[4] 方洪松,周建林,彭昊,等. 不同来源间充质干细胞生物学特性差异. 中国组织工程研究, 2015,19(32):5243-5248. Fang H S,Zhou J L,Peng H,et al. Biological characteristics of different sources of mesenchymal stem cells. Journal of Clinical Rehabilitative Tissue Engineering Research, 2015,19(32):5243-5248.
[5] Nowakowski A, Walczak P, Janowski M,et al. Genetic engineering of mesenchymal stem cells for regenerative medicine. Stem Cells Dev, 2015,24(19):2219-2242.
[6] Nowakowski A, Walczak P, Lukomska B, et al. Genetic engineering of mesenchymal stem cells to induce their migration and survival. Stem Cell International in press.[2017-02-14]. https://www.hindawi.com/journals/sci/2016/4956063/.
[7] Gauthaman K, Fong C Y, Cheyyatraivendran S, et al. Extra-embryonic human Wharton's jelly stem cells do not induce tumorigenesis, unlike human embryonic stem cells. Reprod Biomed Online, 2012,24(2):235-246.
[8] Ganta C, Chiyo D, Ayuzawa R, et al. Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation. Cancer Res, 2009,69(5):1815-1820.
[9] Ding D C,Shyu W C,Lin S Z. Mesenchymal stem cells.Cell Transplant,2011,20(1):5-14.
[10] Yan C H, Yang M,Li Z Z, et al.Suppressionof orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter. Biomaterials, 2014,35(9):3035-3043.
[11] Rachakatla R S, Marini F, Weiss M L,et al. Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors. Cancer Gene Ther, 2007,14(10):828-835.
[12] 胡文龙,吴平平,耿书国,等. 人脐带间充质干细胞分泌白细胞介素6促进骨肉瘤细胞增殖和迁移. 中国病理生理杂志, 2016, 32(2):201-207. Hu W L,Wu P P,Geng S G,et al. Chinese Journal of Pathophysiology, 2016,32(2):201-207.
[13] Dittmar T, Entschladen F.Migratory properties of mesenchymal stem cells.Adv Biochem Eng Biotechnol, 2013,129:117-136.
[14] Janssen A, Medema R H. Entosis:aneuploidy by invasion. Nat Cell Biol, 2011,13(3):199-201.
[15] Wang M, Ning X, Chen A, et al. Impaired formation of homotypic cell-in-cell structures in human tumor cells lacking alpha-catenin expression.[2017-02-14].http://www.nature.com/articles/srep12223.
[16] Krishna S, Overholtzer M.Mechanisms and consequences of entosis.Cell Mol Life Sci, 2016,73(11-12):2379-2386.
[17] Chao K C, Yang H T, Chen M. Human umbilical cord mesenchymal stem cells suppress breast cancer tumourigenesis through direct cell-cell contact and internalization. J Cell Mol Med, 2012,16(8):1803-1815.
[18] Wolf P. The nature and signifiance of platelet products in human plasma. Br J Haematol, 1967,13(3):269-88.
[19] Im H, Shao H, Park Y I, et al. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor.Nature Biotechnology, 2014,32(5):490-495.
[20] Robbins P D, Morelli A E. Regulation of immune responses by extracellular vesicles. Nature Reviews Immunology, 2014,14(3):195-208.
[21] Lee J K, Park S R, Jung B K, et al. Exosomes derived from mesenchymal stem cells suppress angiogenesis by downregulating VEGF expression in breast cancer cells. PLoS One, 2013,8(12):e84256.
[22] Roccaro A M, Sacco A, Maiso P, et al. BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. Journal of Clinical Investigation, 2013,123(4):1542-1555.
[23] Akyurekli C, Le Y, Richardson R B, et al. A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles. Stem Cell Reviews and Reports, 2015, 11(1):150-160.
[24] 王喜梅. 微囊泡在组织再生中的研究进展. 医学综述, 2012, 18(13):1993-1995. Wang X M. Research advances of microvesicles in tissue regeneration.Medical Recapitulate, 2012, 18(13):1993-1995.
[25] Akyurekli C, Le Y, Richardson R B, et al. A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles. Stem Cell Reviews and Reports, 2015, 11(1):150-160.
[26] Wu S, Ju G Q, Du T,et al. Microvesicles derived from human umbilical cord wharton's jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo.PLoS One, 2013,8(4):e61366.
[27] Yang C,Mwaikambo B R,Zhu T, et al. Lymphocytic microparticles inhibit angiogenesis by stimulating oxidative stress and negatively regulating VEGF-induced pathways. Am J Physiol Regul Integr Comp Physiol, 2008,294(2):R467-R476.
[28] Wong V L, Rieman D J, Aronson L,et al. Growth-inhibitory activity of interferon-beta against human colorectal carcinoma cell lines. Int J Cancer, 1989,43(3):526-530.
[29] Shen C J, Chan T F, Chen C C, et al.Human umbilical cord matrix-derived stem cells expressing interferon-β gene inhibit breast cancer cells via apoptosis. Oncotarget, 2016,7(23):34172-34179.
[30] Walczak H, Miller R E, Ariail K, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med, 1999,5(2):157-163.
[31] Yan C, Yang M, Li Z Z, et al.Suppressionof orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter. Biomaterials, 2014,35(9):3035-3043. |
